Clariant showcases VitiPure portfolio at CPHI India
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The investment in land is Rs. 19.85 crore
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
Investment will fund expansion to meet rising demand for CRDMO services
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
State-of-the-art laboratory to support ingredient and specialty chemical innovation, product formulation application development and more sustainable solutions across Europe and beyond
Subscribe To Our Newsletter & Stay Updated